Overview
Synchron's Australian operations and clinical trial hub developed the Stentrode, a minimally invasive endovascular BCI implanted via a blood vessel without open brain surgery. Their device has enabled ALS patients to control computers and smartphones through motor imagery.
More in Brain-Computer Interfaces
Latest industry news
Cala Health Launches Next-Generation TAPS Therapy Wearable Nationwide for Tremor and Parkinson's Patients
2026-10-11 · Product
A New Neurotech Startup Launches to Challenge Sam Altman's Merge Labs in the BCI Race
2026-10-10 · Industry
Butterfly Network Teams Up With Bridge Neurotech to Chase Ultrasound-Based Brain-Computer Interfaces
2026-10-09 · Industry
Paradromics Hits Four-Year Mark for Stable Neural Recording in Landmark BCI Durability Milestone
2026-10-08 · Research
Company details
Category
🧠 Brain-Computer Interfaces
Location
Melbourne, Australia
Funding
Series B · $75M
Website
synchron.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →